Recombinant multi-species SCD5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SCD5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Stearoyl-CoA desaturase (SCD; EC 1.14.99.5) is an integral membrane protein of the endoplasmic reticulum that catalyzes the formation of monounsaturated fatty acids from saturated fatty acids. SCD may be a key regulator of energy metabolism with a role in obesity and dislipidemia. Four SCD isoforms, Scd1 through Scd4, have been identified in mouse. In contrast, only 2 SCD isoforms, SCD1 (MIM 604031) and SCD5, have been identified in human. SCD1 shares about 85% amino acid identity with all 4 mouse SCD isoforms, as well as with rat Scd1 and Scd2. In contrast, SCD5 shares limited homology with the rodent SCDs and appears to be unique to primates (Wang et al., 2005 [PubMed 15907797]).[supplied by OMIM, Mar 2008]
The Alternative Names of target: ACOD4,Acyl-CoA-desaturase 4,DFNA79,FADS4,HSCD5,SCD2,SCD4,SCD5,Stearoyl-CoA 9-desaturase,Stearoyl-CoA desaturase 2,Stearoyl-CoA desaturase 5

Target products collectionGo to SCD5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP1583-Ag-1/ GM-Tg-hg-IP1583-Ag-2 Human SCD5 protein Human
GM-Tg-rg-IP1583-Ag-1/ GM-Tg-rg-IP1583-Ag-2 Rat SCD5 protein Rat
GM-Tg-mg-IP1583-Ag-1/ GM-Tg-mg-IP1583-Ag-2 Mouse SCD5 protein Mouse
GM-Tg-cynog-IP1583-Ag-1/ GM-Tg-cynog-IP1583-Ag-2 Cynomolgus/Rhesus macaque SCD5 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP1583-Ag-1/ GM-Tg-felg-IP1583-Ag-2 Feline SCD5 protein Feline
GM-Tg-cang-IP1583-Ag-1/ GM-Tg-cang-IP1583-Ag-2 Canine SCD5 protein Canine
GM-Tg-bovg-IP1583-Ag-1/ GM-Tg-bovg-IP1583-Ag-2 Bovine SCD5 protein Bovine
GM-Tg-equg-IP1583-Ag-1/ GM-Tg-equg-IP1583-Ag-2 Equine SCD5 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP1583-Ag-1/ GM-Tg-hg-IP1583-Ag-2; GM-Tg-rg-IP1583-Ag-1/ GM-Tg-rg-IP1583-Ag-2;
GM-Tg-mg-IP1583-Ag-1/ GM-Tg-mg-IP1583-Ag-2; GM-Tg-cynog-IP1583-Ag-1/ GM-Tg-cynog-IP1583-Ag-2;
GM-Tg-felg-IP1583-Ag-1/ GM-Tg-felg-IP1583-Ag-2; GM-Tg-cang-IP1583-Ag-1/ GM-Tg-cang-IP1583-Ag-2;
GM-Tg-bovg-IP1583-Ag-1/ GM-Tg-bovg-IP1583-Ag-2; GM-Tg-equg-IP1583-Ag-1/ GM-Tg-equg-IP1583-Ag-2
Products Name SCD5 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name SCD5
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SCD5 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.